Predicting the tumor response to radiotherapy using microarray analysis (Review)
- PMID: 17914580
Predicting the tumor response to radiotherapy using microarray analysis (Review)
Abstract
Predicting the tumor response to radiotherapy is one of the major goals of human cancer treatment. Identification of the genes that are differentially expressed between radiosensitive and radioresistant cancers by global gene analysis may provide new insights into the mechanisms underlying clinical radioresistance and improve the efficacy of radiotherapy. In this study, we reviewed the published reports identifying sets of discriminating genes using microarray analysis that can be used for characterization and the prediction of response to radiotherapy in human cancers. These reports indicate that many of the identified genes were associated with DNA-repair, apoptosis, growth factor, signal transduction, cell cycle and cell adhesion. Several genes were found to be predictors of the radiation response with various cancers and certain sets of identified genes were also found to predict the radiation response by using clustering analysis. Global gene expression profiling of responders and non-responders can be useful in predicting responses to radiotherapy and may also provide insights into the development of individualized therapies and novel therapeutic targets.
Similar articles
-
Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.Int J Oncol. 2006 Mar;28(3):705-13. Int J Oncol. 2006. PMID: 16465376
-
Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.Dis Colon Rectum. 2007 Sep;50(9):1342-53. doi: 10.1007/s10350-007-277-7. Dis Colon Rectum. 2007. PMID: 17665260
-
Differential expression profiling of gene response to ionizing radiation in two endometrial cancer cell lines with distinct radiosensitivities.Oncol Rep. 2009 Mar;21(3):625-34. Oncol Rep. 2009. PMID: 19212620
-
Gene-expression profiling in epithelial ovarian cancer.Nat Clin Pract Oncol. 2008 Oct;5(10):577-87. doi: 10.1038/ncponc1178. Epub 2008 Jul 22. Nat Clin Pract Oncol. 2008. PMID: 18648354 Review.
-
Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy.Eur J Surg Oncol. 2006 Feb;32(1):55-64. doi: 10.1016/j.ejso.2005.09.010. Epub 2005 Dec 1. Eur J Surg Oncol. 2006. PMID: 16324817 Review.
Cited by
-
Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells.Cancer Biol Ther. 2016;17(2):208-18. doi: 10.1080/15384047.2016.1139232. Cancer Biol Ther. 2016. PMID: 26901847 Free PMC article.
-
Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients.Radiat Oncol. 2016 Mar 22;11:50. doi: 10.1186/s13014-016-0623-9. Radiat Oncol. 2016. PMID: 27005571 Free PMC article.
-
Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance.Med Mol Morphol. 2017 Dec;50(4):195-204. doi: 10.1007/s00795-017-0171-x. Epub 2017 Oct 24. Med Mol Morphol. 2017. PMID: 29067564 Review.
-
A Genome-Scale CRISPR Knock-Out Screen Identifies MicroRNA-5197-5p as a Promising Radiosensitive Biomarker in Colorectal Cancer.Front Oncol. 2021 Jul 30;11:696713. doi: 10.3389/fonc.2021.696713. eCollection 2021. Front Oncol. 2021. PMID: 34395263 Free PMC article.
-
Association between radiation-induced cell death and clinically relevant radioresistance.Histochem Cell Biol. 2018 Dec;150(6):649-659. doi: 10.1007/s00418-018-1728-z. Epub 2018 Sep 20. Histochem Cell Biol. 2018. PMID: 30232589 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources